SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB
http://www.w3.org/2000/01/rdf-schema#comment
"The mean percentage of CD33-positivity of the myeloblast population was 80.5% in acute myeloid leukemia (AML) 81.8% in chronic myelomonocytic leukemia (CMML) and 75% in myelodysplastic syndromes (MDS)."
xsd:string
http://purl.uniprot.org/uniprot/#_A92E20E9541F5DB2FC823BFF7E2D6A4DE348A1A82C67DB10EB1B200548DACCE4E64584C2818FF01549C9E05E1623DF86
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB
http://purl.uniprot.org/uniprot/Q546G0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB
http://purl.uniprot.org/uniprot/#_Q546G0-mappedCitation-26726757
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/FEE0B7AD43BD8AA3A7DA7A11A003CF4591E1A09266DDCF27197954C6C306E0BD59B7EE1E3C25726168962E50A1507CFB